Order Article Reprints

Weich A, Werner RA, Buck AK, Hartrampf PE, Serfling SE, Scheurlen M, Wester H-J, Meining A, Kircher S, Higuchi T, et al. CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics. 2021; 11(4):605. https://doi.org/10.3390/diagnostics11040605

Weich, Alexander, Rudolf A. Werner, Andreas K. Buck, Philipp E. Hartrampf, Sebastian E. Serfling, Michael Scheurlen, Hans-Jürgen Wester, Alexander Meining, Stefan Kircher, Takahiro Higuchi, and et al. 2021. "CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas" Diagnostics 11, no. 4: 605. https://doi.org/10.3390/diagnostics11040605

Weich, A., Werner, R. A., Buck, A. K., Hartrampf, P. E., Serfling, S. E., Scheurlen, M., Wester, H.-J., Meining, A., Kircher, S., Higuchi, T., Pomper, M. G., Rowe, S. P., Lapa, C., & Kircher, M. (2021). CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics, 11(4), 605. https://doi.org/10.3390/diagnostics11040605